Core Insights - JinHao Medical (920925.BJ) reported its Q3 2025 results on October 29, 2025, with a total of 9 institutional investors holding 23.7976 million A-shares, representing 24.17% of the total share capital [1] - The institutional holding ratio increased by 0.34 percentage points compared to the previous quarter [1] - One new public fund, Xinghua Jingcheng Mixed A, was disclosed this period, while two public funds were not disclosed compared to the previous quarter [1] Institutional Holdings - The total number of institutional investors holding shares in JinHao Medical is 9, with a combined holding of 23.7976 million shares [1] - The institutional investors include Huizhou Jintongchuang Investment Co., Ltd., Huizhou Jintongsheng Investment Partnership, and several private equity funds managed by Zhongtou Dinghong [1] - The increase in institutional holding ratio indicates growing confidence among institutional investors [1] Public Fund Activity - One new public fund was disclosed this quarter, which is Xinghua Jingcheng Mixed A [1] - Two public funds, namely E Fund North Exchange Selected Two-Year Open Mixed A and CITIC Securities Vision Return A, were not disclosed this quarter [1] Foreign Investment Trends - One foreign fund, Bole Far East Limited, reduced its holdings by 1.27% compared to the previous quarter [2]